Skip to main content

Table 2 Summary of incidence, disease-free survival, and pattern of brain metastasis [32, 33, 37]

From: Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review

Primary Site

Incidence

Median Disease-Free Interval

Only site of metastatic disease

Solitary metastasis

Ovarian (n = 521)

1.19 % (413/34 728)

24.3 months (11–46)

46.8 % (236/504)

41.9 % (205/489)

Endometrial (n = 115)

0.59 % (61/10 199)

17 months (2–108)

49 % (48/98)

56.8 % (50/88)

Cervical (n = 100)

0.57 % (n = 65/11 249)

18 months (0.25-105 months)

46.8 % (37/79)

50.6 % (40/79)